Centene (CNC) is a publicly traded Healthcare sector company. As of May 20, 2026, CNC trades at $58.02 with a market cap of $28.75B and a P/E ratio of -4.53. CNC moved -1.98% today. Year to date, CNC is +41.57%; over the trailing twelve months it is -3.90%. Its 52-week range spans $25.08 to $75.35. Analyst consensus is buy with an average price target of $51.80. Rallies surfaces CNC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CNC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CNC recently traded at $58.02. Market cap is $28.75B. P/E ratio is -4.53. Revenue is $198.10B.
| Metric | Value |
|---|---|
| Price | $58.02 |
| Market Cap | $28.75B |
| P/E Ratio | -4.53 |
| EPS | $-13.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $75.35 |
| 52-Week Low | $25.08 |
| Volume | 1.29M |
| Avg Volume | 0 |
| Revenue (TTM) | $198.10B |
| Net Income | $-6.45B |
| Gross Margin | 7.36% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $194.78B | $-6.68B | $-13.53 |
| 2024 | $163.07B | $3.29B | $6.33 |
| 2023 | $154.00B | $2.70B | $4.97 |
| 2022 | $144.55B | $1.20B | $2.09 |
16 analysts cover CNC: 0 strong buy, 6 buy, 9 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $51.80.